Always I am indebted. J-BOX official store.
The Tokyo metropolitan government announced on the 27th that 154 new people were infected with the new coronavirus and 11 people died. It was the first time since 187 on March 22 that the daily number of infected people fell below 200. There are 125 critically ill patients currently hospitalized. The weekly average number of new infections was 341.6, 44.3% of the previous week as of the 27th. The total number of patients in Tokyo has reached 374,683.
In addition, it seems that the government has announced that it will completely lift the state of emergency, and it has been a year and a half since the outbreak of the coronavirus, and we have finally made great progress.
Well, there was also an article like the following, so optimism is coming out one after another! !
Optimism that the novel coronavirus will be contained within a year and people will be able to return to their daily lives is growing among vaccine developers. But only on the assumption that vaccination coverage will be high and the vaccine gap between rich and poor countries will be closed.
According to The Washington Post (WP), Moderna CEO Stephan Bansel said in an interview with the Swiss daily Neue Zürcher Zeitung (NZZ) on the 23rd (local time) that he would be able to return to normal life next year. In response to the question, "I think it will be possible within a year from today," he replied. Mr. Bancel cites the fact that production of Covid-19 vaccines has expanded across the vaccine industry, making it possible to secure sufficient supplies of vaccines.
"By the middle of next year, it is expected that we will have enough vaccines to vaccinate everyone on the planet," he said, adding that " booster shots will be available as needed." He predicted that booster shots would be needed every 1-3 years.
"At the end of the day, Covid-19 should be flu-like, with timely vaccinations to get through the winter without problems, and not vaccinations at the risk of hospitalization," Bancel said. talked. Vaccine developers at British pharmaceutical company AstraZeneca have also expressed the view that the novel coronavirus will be treated at the level of a common cold. Professor Sarah Gilbert and Professor John Bell of Oxford University, who jointly developed the vaccine with AstraZeneca , expressed the view that a stronger mutant than the delta strain is unlikely to emerge. Professor Gilbert said, ``The virus spreads among people with strong immunity , and the fatality rate gradually decreases.'' Let's go," he said. Professor Bell also evaluated the UK, where more people are getting vaccinated, saying that "the worst is over" and that "the spread of the virus appears to be weakening as the vaccination rate increases." Former US Food and Drug Administration (FDA) Director Scott Gottlieb, who is now on the board of Pfizer, also said, "Delta stock will be the last of the pandemic." Gottlieb was open to the idea that Covid-19 would be a seasonal disease, assuming that no mutants emerge that evade vaccine immunity.
He also said that raising the vaccination rate is a top priority for the new corona to become endemic. Gottlieb cautiously mentioned the future of coexistence with the novel coronavirus, saying, ``If 80 to 85% of the US population is vaccinated, the number of infections will decrease and the pace of spread will begin to slow down.''
He predicted that booster shots would be needed every 1-3 years.
At that time, I believe that our "J-BOX BIO MISSION series", a cold insulation box for vaccines, will continue to play an active role.
For Pfizer Vaccines:
See you tomorrow! !